Global Anticoagulants Growth Rate Is At 6.03% From 2012 To 2016
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, global market of anticoagulants developed rapidly. In 2016, global revenue of anticoagulants is nearly 20000 M USD. And the global growth rate is at 6.03% from 2012 to 2016.
The classification of anticoagulants includes PAI, LMWH, DTI, DFXa, VKA, and Other, and the proportion of PAI in 2016 is about 31.07%, and the proportion is in decreasing quickly from 2012 to 2016. The market for DFXa, is growth quickly in past five years the market share increase from 7.45% in 2016 to 26.67% in 2016.
Anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of anticoagulants used to treat AF, and the revenue in 2016 is 13118 M USD.
Europe region is the largest supplier of anticoagulants, with a production market share nearly 56.40% in 2016. North America is the second largest supplier of anticoagulants, enjoying production market share nearly 26.35% in 2016.
North America is the largest consumption place, with a consumption market share nearly 39.72% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26.83%..
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche), Boehringer Ingelheim etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.